| Old Articles: <Older 9501-9510 Newer> |
 |
The Motley Fool September 8, 2005 Tim Beyers |
Dueling Fools: Google Bull Anything you can do, Google can do better. Google is aiming for it all. But it's not treading lightly. The decline in stock price in recent months ought to be great news for the investor in you.  |
The Motley Fool September 8, 2005 Steven Mallas |
WWE: Hulkin' Up? WWE shows some signs of life. The company currently sports a yield well over 3%, so you do get paid to invest with this one. Long holding periods may yield very fruitful results if you decide to tag-team some of your investment capital with this stock.  |
The Motley Fool September 8, 2005 M.D. Mitchell |
Sabre Ready to Fly Can Travelocity get the travel giant back off the ground? With Sabre producing plenty of cash and trading at a P/E near 12, investors could have reason for soaring hopes if the current trends continue.  |
The Motley Fool September 8, 2005 Rich Smith |
Korn/Ferry Torpedoed The headhunter's profits rise, predictions disappoint, but the hull is sound. With a bright future, expanding margins, and an apparent commitment to let outside shareholders share more equally, this looks like one stock that could really float investors' boats.  |
The Motley Fool September 8, 2005 Jeremy MacNealy |
Take-Two Sits This One Out The company loses in its latest quarter. Its stock will likely continue to feel pressure over the next several weeks. While some head for the exits, it may be a good time to take a closer look at this company's performance.  |
The Motley Fool September 7, 2005 W.D. Crotty |
McCormick's Bland Outlook The spice company is looking to improve efficiency, but will investors find the move palatable?  |
The Motley Fool September 7, 2005 W.D. Crotty |
Shuffling Back the Shorts Shuffle Master reports an excellent third quarter, and the shorts are probably running for cover.  |
The Motley Fool September 7, 2005 Nathan Parmelee |
Be Wary of Headlines Some headlines are overstating the extent of the damages investors can expect to endure. As investors, we need to consider the big picture for each company we own and put the numbers in the stories into context.  |
The Motley Fool September 7, 2005 Stephen D. Simpson |
Smashing Good Deal, Eh? Glaxo's purchase of Canadian ID Biomedical will seriously augment its vaccine capabilities. Investors, take note.  |
The Motley Fool September 7, 2005 Stephen D. Simpson |
In the Wake of Katrina: Energy The disruptions to the Gulf's energy infrastructure will have far-reaching effects for who knows how long? With demand unlikely to drop off in any meaningful way, there are still ample opportunities in the global energy sector for sharp-eyed investors.  |
| <Older 9501-9510 Newer> Return to current articles. |